Overview

The TARGET BP OFF-MED Trial

Status:
Active, not recruiting

Trial end date:
2023-03-01

Target enrollment:

Participant gender:

Summary

To obtain an assessment of the efficacy and safety of renal denervation by alcohol-mediated neurolysis using the Peregrine Kit in hypertensive subjects in the absence of antihypertensive medications.

Phase:

Phase 2

Details

Lead Sponsor:

Ablative Solutions, Inc.

Treatments:

Ethanol